The autophagy inhibitor chloroquine overcomes the innate resistance to erlotinib of non-small cell lung cancer cells with wild-type EGFR

Por Zou, Yiyu, Ling, Yi-He, Sironi, Juan, Schwartz, Edward L., Perez-Soler, Roman, Piperdi, Bilal
Publicado em 2013

Survival in Women with NSCLC: The Role of Reproductive History and Hormone Use

Por Katcoff, Hannah, Wenzlaff, Angela S., Schwartz, Ann G.
Publicado em 2014

National Patterns of Care and Outcomes after Combined Modality Therapy for Stage IIIA Non-small Cell Lung Cancer

Por Patel, Aalok P., Crabtree, Traves D., Bell, Jennifer M., Guthrie, Tracey J., Robinson, Clifford G., Morgensztern, Daniel, Colditz, Graham A., Kreisel, Daniel, Krupnick, A. Sasha, Bradley, Jeffrey D., Patterson, G. Alexander, Meyers, Bryan F., Puri, Varun
Publicado no J Thorac Oncol (2014)

Heat Shock Protein 90 Inhibition in Lung Cancer

Por Shimamura, Takeshi, Shapiro, Geoffrey I.
Publicado no J Thorac Oncol (2008)

Socioeconomic status is associated with depressive severity among patients with advanced non-small cell lung cancer: Treatment setting and minority status do not make a difference

Por Fagundes, Christopher, Jones, Desiree, Vichaya, Elisabeth, Lu, Charles, Cleeland, Charles S.
Publicado no J Thorac Oncol (2014)

Should never-smokers at increased risk for lung cancer be screened?

Por Haaf, Kevin ten, de Koning, Harry J.
Publicado no J Thorac Oncol (2015)

Refining prognosis in lung cancer: A report on the quality and relevance of clinical prognostic tools

Por Mahar, Alyson L., Compton, Carolyn, McShane, Lisa M., Halabi, Susan, Asamura, Hisao, Rami-Porta, Ramon, Groome, Patti A.
Publicado no J Thorac Oncol (2015)

RET Rearrangements in Lung Adenocarcinoma and Radiation

Por Dacic, Sanja, Luvison, Alyssa, Evdokimova, Viktoria, Kelly, Lindsey, Siegfried, Jill M., Villaruz, Liza C., Socinski, Mark A., Nikiforov, Yuri E.
Publicado no J Thorac Oncol (2014)

Pulse afatinib for ERBB2 exon 20 insertion mutated lung adenocarcinomas

Por Costa, Daniel B., Jorge, Susan E., Moran, Jason P., Freed, Jason A., Zerillo, Jessica A., Huberman, Mark S., Kobayashi, Susumu S.
Publicado no J Thorac Oncol (2016)

PI3K as a potential therapeutic target in thymic epithelial tumors

Por Alberobello, Anna Teresa, Wang, Yisong, Beerkens, Frans Joseph, Conforti, Fabio, McCutcheon, Justine N, Rao, Guanhua, Raffeld, Mark, Liu, Jing, Rahhal, Raneen, Zhang, Yu-Wen, Giaccone, Giuseppe
Publicado no J Thorac Oncol (2016)

An anaplastic lymphoma kinase (ALK) immunohistochemistry negative but fluorescence in situ hybridization (FISH) positive lung adenocarcinoma is resistant to Crizotinib

Por Shi, Ruoshi, Varella-Garcia, Marileila, Li, Ming, Ludkovski, Olga, Danesh, Arnavaz, Christine, Ng, Pham, Nhu-An, Pugh, Trevor, Shepherd, Frances A., Tsao, Ming-Sound
Publicado no J Thorac Oncol (2016)

Spread Through Air Spaces (STAS) is an Independent Predictor of Recurrence and Lung Cancer Specific Death in Squamous Cell Carcinoma

Por Lu, Shaohua, Tan, Kay See, Kadota, Kyuichi, Eguchi, Takashi, Bains, Sarina, Rekhtman, Natasha, Adusumilli, Prasad S., Travis, William D.
Publicado no J Thorac Oncol (2016)

Histone Deacetylase Inhibitor Romidepsin Enhances Anti-Tumor Effect of Erlotinib in Non-small Cell Lung Cancer (NSCLC) Cell Lines

Por Zhang, Wei, Peyton, Michael, Xie, Yang, Soh, Junichi, Minna, John D., Gazdar, Adi F., Frenkel, Eugene P.
Publicado em 2009

Sequential Molecular Changes during Multistage Pathogenesis of Small Peripheral Adenocarcinomas of the Lung

Por Soh, Junichi, Toyooka, Shinichi, Ichihara, Shuji, Asano, Hiroaki, Kobayashi, Naruyuki, Suehisa, Hiroshi, Otani, Hiroki, Yamamoto, Hiromasa, Ichimura, Kouichi, Kiura, Katsuyuki, Gazdar, Adi F., Date, Hiroshi
Publicado em 2008

Brief Report: Variation in Experts’ Beliefs about Lung Cancer Growth, Progression and Prognosis

Por Schultz, Ellen M., Silvestri, Gerard A., Gould, Michael K.
Publicado em 2008

Features of Potentially Predictive Biomarkers of Chemotherapeutic Efficacy in Small Cell Lung Cancer

Por Chiappori, Alberto A., Zheng, Zhong, Chen, Tingan, Rawal, Bhupendra, Schell, Michael J., Mullaney, Brian P., Bepler, Gerold
Publicado em 2010

Clinical Features of Bronchioloalveolar Carcinoma with New Histologic and Staging Definitions

Por Ebbert, Jon O., Chhatwani, Laveena, Aubry, Marie Christine, Wampfler, Jason, Stoddard, Shawn, Zhang, Fang, Qiao, Guibin, de Andrade, Mariza, Yang, Ping
Publicado em 2010

Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: A phase II Southwest Oncology Group study (S0339)

Por Davies, Angela M., Chansky, Kari, Lara, Primo N., Gumerlock, Paul H., Crowley, John, Albain, Kathy S., Vogel, Stanley J., Gandara, David R.
Publicado em 2009

Genetic and epigenetic analysis of erbB signaling pathway genes in lung cancer

Por Hoque, Mohammad Obaidul, Brait, Mariana, Rosenbaum, Eli, Poeta, Maria Luana, Pal, Prodipto, Begum, Shahnaz, Dasgupta, Santanu, Carvalho, Andre L, Ahrendt, Steven A., Westra, William H, Sidransky, David
Publicado em 2010

Genetic and Proteomic Features Associated with Survival after Treatment with Erlotinib in First-Line Therapy of Non-small Cell Lung Cancer in Eastern Cooperative Oncology Group 350...

Por Amann, Joseph M., Lee, Ju-Whei, Roder, Heinrich, Brahmer, Julie, Gonzalez, Adriana, Schiller, Joan H., Carbone, David P.
Publicado em 2010